High-throughput immunoassays for SARS-CoV-2 - considerable differences in performance when comparing three methods.

The results of the evaluated SARS-CoV-2 assays vary considerably, as well as their ability to fulfil the performance criteria proposed by regulatory authorities. Introduction into clinical use in low-prevalent settings, should, therefore, be made with caution.